JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $14
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $15 to $14.
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $15 to $14.